(redirected fromDispensable Drug Identifier) AcronymDefinition DDIDDivision of Developmental and Intellectual Disabilities(Kentucky) DDIDDetection, Diagnosis and Intervention in Dementia(Pennsylvania) DDIDDutch Design in Development(National Committee for International Cooperation and Sustainable Development; Amsterda...
logger.warn("Could not find name for this drug! "+ drug.getId()); }if(drug.getRegionalIdentifier() !=null&& !drug.getRegionalIdentifier().isEmpty()) {try{ medication.setMedicationDIN(drug.getRegionalIdentifier()); }catch(NumberFormatException e) { logger.warn("regional identifier is not a...
IDLIdentifier List IDLImmediately Dangerous to Life IDLInternational Date Line IDLInstructional Design and Learning IDLIndirect Labor IDLImport Drug License(China) IDLIndependent and Distance Learning(various locations) IDLInternational Driving License
currently set at one month. In order to handle the data changes during updates, we backup the RDF graph holding our dataset and replace it with the newly created RDF graph. With this we employ versioning and maintain the default graph identifier to always denote the latest version of the Lin...
KnowDrugs is the easiest way to lookup drug testing results, pill warnings and drug alerts and provides you with drug info about more than 200 drugs, along with advice on harm reduction and safer use. Taking drugs always involves risks - however, if you do decide to take drugs, KnowDrugs...
An extension of the InChI, RInChI [18,70], was developed between 2008 and 2018 and introduced a unique, order invariant identifier for reactions. It was developed in response to the growing size of reaction data to aid reproducibility, to consider more information than just the participating mo...
Phase A. 3 telavancin Staphylococcus aureus (S. aureus) bacteremia Trial (identifier NCT02208063): National Library of Medicine, NIH (2020) ; [Available from: https://clinicaltrials.gov/ct2/show/NCT02208063] Garcia B, Gonzalez J, Chaudhry S (2021) Clinical outcomes for telavancin for salvage...
Unique identifier: NCT 00351260.doi:10.1161/CIRCULATIONAHA.109.888297David HildickSmithAdam J. de BelderNina CooterNicholas P. CurzenTim C. ClaytonKeith G. OldroydLorraine BennettSteve HolmbergJames M. CottonPeter E. GlennonOvid Technologies (Wolters Kluwer Health)Circulation...
Unique identifier: [NCT01186120][1]. [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT01186120&atom=%2Fcirccvint%2Fearly%2F2014%2F05%2F13%2FCIRCINTERVENTIONS.113.000841.atom 展开 关键词: Angioplasty Biolimus Coronary artery disease Everolimus Stents ...
8. The system of claim 1, wherein the drug identification component, the storage medium and the processor are locally connected to generate the label content without a networked lookup. 9. The system of claim 1, wherein the machine-readable content encodes a unique identifier that functions as...